Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma
暂无分享,去创建一个
E. Ruffini | J. Vignaud | N. Santelmo | M. Beau-Faller | P. Falcoz | F. Guerrera | A. Tiotiu | G. Massard | J. Siat | Anna Voegeli | L. Costardi | C. Clément‐Duchêne | J. Seitlinger | J. Reeb | S. Renaud